Published in J Exp Med on January 01, 2001
DC-based cancer vaccines. J Clin Invest (2007) 3.81
Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J Exp Med (2005) 3.63
Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells. J Clin Invest (2003) 1.70
CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice. Proc Natl Acad Sci U S A (2011) 1.41
Qa-1 restriction of CD8+ suppressor T cells. J Clin Invest (2004) 1.41
Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines. J Clin Invest (2006) 1.40
Functional avidity directs T-cell fate in autoreactive CD4+ T cells. Blood (2005) 1.39
The strength of persistent antigenic stimulation modulates adaptive tolerance in peripheral CD4+ T cells. J Exp Med (2003) 1.38
TCR recognition of peptide/MHC class II complexes and superantigens. Semin Immunol (2007) 1.30
Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2003) 1.27
Memory generation and maintenance of CD8+ T cell function during viral persistence. J Immunol (2007) 1.23
HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes. J Clin Invest (2010) 1.18
Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selection. EMBO J (2011) 1.17
Perceiving the avidity of T cell activation can be translated into peripheral T cell regulation. Proc Natl Acad Sci U S A (2007) 1.16
Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses. Proc Natl Acad Sci U S A (2012) 1.16
Attenuated T cell responses to a high-potency ligand in vivo. PLoS Biol (2010) 1.15
Mobilizing the low-avidity T cell repertoire to kill tumors. Semin Cancer Biol (2007) 1.08
Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors. Trends Biochem Sci (2007) 1.07
Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia. Blood (2007) 1.05
Functional avidity: a measure to predict the efficacy of effector T cells? Clin Dev Immunol (2012) 1.01
HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives. J Immunol (2012) 0.97
Peptide-MHC class II complex stability governs CD4 T cell clonal selection. J Immunol (2009) 0.96
Activation-threshold tuning in an affinity model for the T-cell repertoire. Proc Biol Sci (2004) 0.94
Reduced self-reactivity of an autoreactive T cell after activation with cross-reactive non-self-ligand. J Exp Med (2002) 0.94
Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice. J Immunol (2008) 0.92
The specificity of T cell regulation that enables self-nonself discrimination in the periphery. Proc Natl Acad Sci U S A (2008) 0.90
Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities. Immunology (2001) 0.90
Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE. J Neuroimmune Pharmacol (2009) 0.89
Drak2 regulates the survival of activated T cells and is required for organ-specific autoimmune disease. J Immunol (2008) 0.89
Autoantigen immunization at different sites reveals a role for anti-inflammatory effects of IFN-gamma in regulating susceptibility to experimental autoimmune encephalomyelitis. J Immunol (2009) 0.88
T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity. Int Rev Immunol (2006) 0.88
Low 2-dimensional CD4 T cell receptor affinity for myelin sets in motion delayed response kinetics. PLoS One (2012) 0.88
HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells. Blood (2011) 0.87
Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4⁺ T-cell repertoire selection. Nat Commun (2012) 0.86
A HCMV pp65 polypeptide promotes the expansion of CD4+ and CD8+ T cells across a wide range of HLA specificities. J Cell Mol Med (2009) 0.85
CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity. Clin Exp Immunol (2012) 0.82
Altered differentiation, diminished pathogenicity, and regulatory activity of myelin-specific T cells expressing an enhanced affinity TCR. J Immunol (2011) 0.82
Stepwise B-cell-dependent expansion of T helper clonotypes diversifies the T-cell response. Nat Commun (2016) 0.79
Antigen signal strength during priming determines effector CD4 T cell function and antigen sensitivity during influenza virus challenge. J Immunol (2014) 0.79
Molecular mimics can induce a nonautoaggressive repertoire that preempts induction of autoimmunity. Proc Natl Acad Sci U S A (2010) 0.78
Narrowing the Gap: Preserving Repertoire Diversity Despite Clonal Selection during the CD4 T Cell Response. Front Immunol (2015) 0.77
Conformational studies of immunodominant myelin basic protein 1-11 analogues using NMR and molecular modeling. J Comput Aided Mol Des (2011) 0.76
Thymic selection can compensate for mutations affecting T cell activation and generate a normal T cell repertoire in mutant mice. Proc Natl Acad Sci U S A (2003) 0.75
Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med (1981) 12.03
Determination of lymphocyte division by flow cytometry. J Immunol Methods (1994) 11.48
The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity (1999) 6.10
Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell (1995) 5.82
Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell (1988) 5.73
Selecting and maintaining a diverse T-cell repertoire. Nature (1999) 5.35
A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today (1998) 5.07
Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol (1999) 4.97
T-cell-receptor affinity and thymocyte positive selection. Nature (1996) 4.96
Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity (1999) 4.61
Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol (1993) 4.23
Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity (1998) 4.15
T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature (1987) 3.96
A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity (1999) 3.88
Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med (1997) 3.53
MHC class II molecules are not required for survival of newly generated CD4+ T cells, but affect their long-term life span. Immunity (1996) 3.20
Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity (1995) 3.18
An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc Natl Acad Sci U S A (1999) 3.15
T cell antigen receptor signal transduction pathways. Annu Rev Immunol (1996) 3.11
T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science (1994) 3.00
Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J Exp Med (1997) 2.95
Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity (2000) 2.94
Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition. Immunity (1999) 2.89
Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell (1989) 2.77
Molecular mimicry and immune-mediated diseases. FASEB J (1998) 2.53
Selection of the T cell repertoire. Annu Rev Immunol (1999) 2.21
Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity (1999) 2.19
An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int Immunol (1993) 2.06
Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity (1998) 1.97
Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc Natl Acad Sci U S A (1996) 1.85
Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc Natl Acad Sci U S A (1992) 1.83
Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol (1993) 1.82
Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol (1999) 1.78
Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J Exp Med (1998) 1.70
Divergent changes in the sensitivity of maturing T cells to structurally related ligands underlies formation of a useful T cell repertoire. Immunity (1999) 1.64
Effector T-cell induction and T-cell memory versus peripheral deletion of T cells. Immunol Rev (1993) 1.61
Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc Natl Acad Sci U S A (1999) 1.56
Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J Exp Med (1995) 1.53
A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1991) 1.45
Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus. Proc Natl Acad Sci U S A (1996) 1.44
The organization of mature T-cell pools. Immunol Today (1998) 1.34
Cross-reactive antigen recognition by an encephalitogenic T cell receptor. Implications for T cell biology and autoimmunity. J Immunol (1992) 1.30
Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines. J Immunol (2000) 1.23
Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity. Proc Natl Acad Sci U S A (1994) 1.18
Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice--implications for autoimmunity. Int Immunol (1995) 1.13
Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms. J Neuroimmunol (1997) 1.09
A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains. Eur J Immunol (2000) 1.06
Myelin basic protein peptide complexes with the class II MHC molecules I-Au and I-Ak form and dissociate rapidly at neutral pH. J Immunol (1995) 1.04
Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. J Exp Med (1997) 1.04
In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis. J Exp Med (1998) 1.00
Genetic models of abnormal apoptosis in lymphocytes. Immunol Rev (1999) 0.99
Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity. J Immunol (1998) 0.97
Termination of peripheral tolerance to a T cell epitope by heteroclitic antigen analogues. J Immunol (1998) 0.97
Detection of autoreactive T cells in H-2u mice using peptide-MHC multimers. Int Immunol (2000) 0.95
The nature of cryptic epitopes within the self-antigen myelin basic protein. Int Immunol (1996) 0.95
Evidence that the autoimmune antigen myelin basic protein (MBP) Ac1-9 binds towards one end of the major histocompatibility complex (MHC) cleft. J Exp Med (1998) 0.94
T cell determinant structure of myelin basic protein in B10.PL, SJL/J, and their F1S. J Immunol (1994) 0.92
Tuning T cell activation threshold and effector function with cross-reactive peptide ligands. Int Immunol (2000) 0.92
Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-Au, which confers susceptibility to experimental allergic encephalomyelitis. Mol Med (1996) 0.92
Quantitative analysis of T cell activation: role of TCR/ligand density and TCR affinity. J Immunol (1996) 0.89
The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope. J Exp Med (1999) 0.88
MHC-binding peptides for immunotherapy of experimental autoimmune disease. J Autoimmun (1992) 0.86
Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease. Immunology (1994) 0.86
Tolerating the nervous system: a delicate balance. J Exp Med (2000) 0.81
A small number of residues in the class II molecule I-Au confer the ability to bind the myelin basic protein peptide Ac1-11. Proc Natl Acad Sci U S A (1999) 0.81
Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell (1988) 5.73
Multiple roles for the major histocompatibility complex class I- related receptor FcRn. Annu Rev Immunol (2000) 3.19
Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity (1995) 3.18
Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur J Immunol (1996) 2.90
Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int Immunol (2001) 2.87
Bacillus thuringiensis var. israelensis delta-endotoxin. Nucleotide sequence and characterization of the transcripts in Bacillus thuringiensis and Escherichia coli. J Mol Biol (1986) 2.62
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature (1996) 2.30
Quantitative study of single molecule location estimation techniques. Opt Express (2009) 2.15
An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int Immunol (1993) 2.06
Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. Int Immunol (1998) 1.96
The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. Int Immunol (2001) 1.93
Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol (1993) 1.82
Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC. Immunol Today (1996) 1.81
Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol (1999) 1.78
Cloning and expression in Escherichia coli of the insecticidal delta-endotoxin gene of Bacillus thuringiensis var. israelensis. FEBS Lett (1984) 1.77
Bacillus thuringiensis var. israelensis delta-endotoxin. Cloning and expression of the toxin in sporogenic and asporogenic strains of Bacillus subtilis. J Mol Biol (1986) 1.74
Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med (1993) 1.71
Induction of influenza A virus cross-reactive cytotoxic T cells by a nucleoprotein/haemagglutinin preparation. J Gen Virol (1985) 1.70
Purified influenza virus nucleoprotein protects mice from lethal infection. J Gen Virol (1987) 1.62
Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn. Eur J Immunol (1999) 1.61
Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor. Eur J Immunol (1994) 1.57
Kinetics and thermodynamics of T cell receptor- autoantigen interactions in murine experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2001) 1.56
A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1991) 1.45
Increasing the serum persistence of an IgG fragment by random mutagenesis. Nat Biotechnol (1997) 1.45
Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1. J Immunol (1997) 1.39
Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo. Int Immunol (1999) 1.31
FcRn: the MHC class I-related receptor that is more than an IgG transporter. Immunol Today (1997) 1.30
Mite asthma. Cause and management. Practitioner (1970) 1.27
Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis. Eur J Immunol (1994) 1.26
The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn. Mol Immunol (1996) 1.23
Crystal structure of the V alpha domain of a T cell antigen receptor. Science (1995) 1.21
Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice--implications for autoimmunity. Int Immunol (1995) 1.13
Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur J Immunol (1998) 1.09
Control of immune interferon release by cytotoxic T-cell clones specific for influenza. Immunology (1985) 1.08
Identification and function of neonatal Fc receptor in mammary gland of lactating mice. Eur J Immunol (1999) 1.08
Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats. J Pharmacol Exp Ther (2000) 1.02
Qualitative and quantitative effects of CD28/B7-mediated costimulation on naive T cells in vitro. J Immunol (1998) 0.99
Influenza peptide-induced self-lysis and down-regulation of cloned cytotoxic T cells. Immunology (1990) 0.99
Catabolism of the murine IgG1 molecule: evidence that both CH2-CH3 domain interfaces are required for persistence of IgG1 in the circulation of mice. Scand J Immunol (1994) 0.98
Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity. J Immunol (1998) 0.97
The nature of cryptic epitopes within the self-antigen myelin basic protein. Int Immunol (1996) 0.95
Detection of autoreactive T cells in H-2u mice using peptide-MHC multimers. Int Immunol (2000) 0.95
Comparative stabilities in vitro and in vivo of a recombinant mouse antibody FvCys fragment and a bisFvCys conjugate. J Immunol (1992) 0.94
Complete characterization of the expressed immune response genes in Biozzi AB/H mice: structural and functional identity between AB/H and NOD A region molecules. Immunogenetics (1993) 0.93
Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis. Ann N Y Acad Sci (1996) 0.93
Predictors of blood product use in orthotopic liver transplantation using the piggyback hepatectomy technique. Transplant Proc (2007) 0.92
Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells. Neuropathol Appl Neurobiol (2011) 0.92
Preparing for first-in-man studies: the challenges for translational immunology post-TGN1412. Clin Exp Immunol (2008) 0.91
Sedimentation equilibrium analysis of recombinant mouse FcRn with murine IgG1. Mol Immunol (2000) 0.91
Influenza virus-specific cytotoxic T-cell recognition: stimulation of nucleoprotein-specific clones with intact antigen. Immunology (1986) 0.90
Crystallization and preliminary X-ray diffraction study of the bacterially expressed Fv from the monoclonal anti-lysozyme antibody D1.3 and of its complex with the antigen, lysozyme. J Mol Biol (1990) 0.90
The role of polymorphic I-Ak beta chain residues in presentation of a peptide from myelin basic protein. J Exp Med (1989) 0.90
Vaccination with a recombinant V alpha domain of a TCR prevents the development of collagen-induced arthritis. J Immunol (1995) 0.89
Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein. J Immunol (1989) 0.89
Inhibition of T-cell responsiveness by nasal peptide administration: influence of the thymus and differential recovery of T-cell-dependent functions. Immunology (1999) 0.88
Kinetics of peptide uptake and tissue distribution following a single intranasal dose of peptide. Immunol Invest (2000) 0.87
Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease. Immunology (1994) 0.86
Comparative studies of rat IgG to further delineate the Fc:FcRn interaction site. Eur J Immunol (1998) 0.86
Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells. J Immunol (1997) 0.85
Induction of a type 1 regulatory CD4 T cell response following V beta 8.2 DNA vaccination results in immune deviation and protection from experimental autoimmune encephalomyelitis. Int Immunol (2001) 0.85
Localization of the site of the IgG molecule that regulates maternofetal transmission in mice. Eur J Immunol (1996) 0.84
Noise suppression of point spread functions and its influence on deconvolution of three-dimensional fluorescence microscopy image sets. J Microsc (2005) 0.84
Differential responses of CD45+ve T-cell subsets to MBP in multiple sclerosis. Clin Exp Immunol (2001) 0.84
Evidence that the hinge region plays a role in maintaining serum levels of the murine IgG1 molecule. Mol Immunol (1995) 0.83
Diversity and dynamics of the T-cell response to MBP in DR2+ve individuals. Clin Exp Immunol (2002) 0.83
The choice of reference cell in the analysis of kinetic data using BIAcore. Anal Biochem (1999) 0.83
Loss of serological determinants does not affect recognition of H-2Kk target cells by an influenza-specific cytotoxic T cell clone. Eur J Immunol (1983) 0.82
Crystallization and preliminary X-ray diffraction study of a bacterially produced T-cell antigen receptor V alpha domain. J Mol Biol (1994) 0.82
Dual conformations of a T cell receptor V alpha homodimer: implications for variability in V alpha V beta domain association. J Mol Biol (1997) 0.82
Antigen-presenting cell activation: a link between infection and autoimmunity? J Autoimmun (2001) 0.82
Immunotherapy of autoimmune disease. Curr Opin Immunol (1993) 0.82
Therapeutic potential of TCR antagonists is determined by their ability to modulate a diverse repertoire of autoreactive T cells. Eur J Immunol (1999) 0.81
Peptide-MHC interaction in autoimmunity. Curr Opin Immunol (1992) 0.81
PET imaging of the immune system: immune monitoring at the whole body level. Q J Nucl Med Mol Imaging (2010) 0.81
Disposition and functions of clarithromycin in human THP-1 monocytes during stimulated and unstimulated conditions. Res Commun Mol Pathol Pharmacol (2001) 0.80
The influence of signal noise on the accuracy of kinetic constants measured by surface plasmon resonance experiments. Anal Biochem (1999) 0.80
Splenic but not thymic autoreactive T cells from New Zealand Black mice respond to a dominant erythrocyte Band 3 peptide. Immunology (1999) 0.80
Generating binding activities from Escherichia coli by expression of a repertoire of immunoglobulin variable domains. Cold Spring Harb Symp Quant Biol (1989) 0.79
Alterations in aminoglycoside volume of distribution in patients below ideal body weight. Clin Pharm (1987) 0.79
Tmolt4 leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones. Arch Pharm (Weinheim) (2001) 0.79
Crystal structure of a T cell receptor Valpha11 (AV11S5) domain: new canonical forms for the first and second complementarity determining regions. J Mol Biol (2001) 0.79
Effect of education on the appropriateness of serum drug concentration determination. Ther Drug Monit (1992) 0.78
Dk-restricted antiinfluenza cytotoxic T-cell clone loses one of its two alloreactivities. Immunogenetics (1984) 0.78
A role for the region encompassing the c" strand of a TCR V alpha domain in T cell activation events. J Immunol (2000) 0.78
Evolution, function, and utilization of major histocompatibility complex polymorphism in autoimmune disease. Cold Spring Harb Symp Quant Biol (1989) 0.78
Identification of an indirectly presented epitope in a mouse model of skin allograft rejection. Transplantation (1998) 0.78
Elevated phenytoin concentration caused by sampling through the drug-administration catheter. Pharmacotherapy (1991) 0.78
Anti-Vbeta8 antibodies induce and maintain staphylococcal enterotoxin B-triggered Vbeta8+ T cell anergy. Eur J Immunol (1999) 0.78
Pharmacokinetics of three formulations of ondansetron hydrochloride in healthy volunteers: 24-mg oral tablet, rectal suppository, and i.v. infusion. Am J Health Syst Pharm (2000) 0.77
Self tolerance to T cell receptor V beta sequences. J Exp Med (1995) 0.77
Cytotoxic T-cell recognition of influenza-infected target cells varies in different H-2k mouse strains. Immunogenetics (1983) 0.77